Once-Daily Fluticasone Furoate Nasal Spray Showed Greater Improvements in Relieving Nighttime Nasal Symptoms and Increasing Peak Nasal Inspiratory Flow Versus Oral Fexofenadine in Subjects With Seasonal Allergic Rhinitis (SAR)

Fluticasone furoate nasal spray (FFNS), a new enhanced-affinity intranasal corticosteroid, and oral fexofenadine (FEX), a non-sedating antihistamine, were compared using a validated nighttime symptom questionnaire (NSS), subject-rated nasal symptoms, and peak nasal inspiratory flow (PNIF), an object...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S54-S55
Main Authors: Martin, B.G, Andrews, C.P, Jacobs, R, Mohar, D, Toler, W.T, Prillaman, B.A, Philpot, E.E
Format: Article
Language:English
Subjects:
Allergies
Allergy and Immunology
Drug therapy
Nose
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fluticasone furoate nasal spray (FFNS), a new enhanced-affinity intranasal corticosteroid, and oral fexofenadine (FEX), a non-sedating antihistamine, were compared using a validated nighttime symptom questionnaire (NSS), subject-rated nasal symptoms, and peak nasal inspiratory flow (PNIF), an objective measure of nasal obstruction.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2007.12.220